chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Pain in extremity
Clinical narrative: upset stomach; sore arm; This is a spontaneous report received from a non-contactable consumer (Patient's wife). A male patient of unspecified age received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose unspecified via an unspecified route of administration on unknown date (Batch/Lot number was not reported) as SINGLE dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had sore arm and upset stomach. The outcome for events were unknown.   No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Rhinorrhoea
Clinical narrative: Runny nose; broke out in a itchy rash over most of my body; This is a spontaneous report from a contactable consumer (patient, self-reported). A 72-year-old (non-pregnant) female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318 59267-1000-01 and expiration date was not reported), via an unspecified route of administration in left arm on 29Jan2021 at 13:00 (at the age of 72 years old) as a 1st dose, single for COVID-19 immunisation. The patient had past drug events with Iodine and hydrocodone. The patient's medical history included Arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has allergic to Iodine and hydrocodone. Concomitant medications included Protein Coffee, Famotidine. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Feb2021 at 13:00 the patient experienced, Runny nose 1-4 days on the 5th day Feb. 3rd she broke out in an itchy rash over most of my body. The patient did not receive any treatment for the events. The reporter reporting the events was non-serious. Facility where the most recent COVID-19 vaccine administered was pharmacy or drug Store. There was no treatment received for the adverse event. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain
Clinical narrative: upper back, through shoulder blades pain/lower back pain; upper back, through shoulder blades pain; This is a spontaneous report from a contactable 56-year-old female nurse (patient, self-reported). A 56-year-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE (age at the time of vaccination was 56 years), Formulation: Solution for injection, Lot number and Expiry date: unknown), dose 2 via an intramuscular route of administration, in the right arm, on 21Jan2021 at 09:15, as single for COVID-19 immunization. The patient's medical history included hypothyroidism, and patient historical vaccine includes, received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry date: unknown), dose 1 via an intramuscular route of administration, in the right arm, on 31Dec2021 at 02:00 PM, as single for COVID-19 immunisation and had reaction right groin pain and right hip pain. The patient's concomitant medications included levothyroxine sodium (SYNTHROID), clonazepam, vortioxetine hydrobromide (TRINTELLIX), colecalciferol (vitamin d), amitriptyline. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received second COVID-19 vaccine on 21Jan2021 and noted upper back, through shoulder blades pain on 22Jan2021, resolved after 24hours. The patient was not tested for COVID-19 since the vaccination. The patient did not receive treatment medications. Outcome of the events back pain, arthralgia was recovered on Jan2021.  Information on the lot/batch number has been requested.  Follow-up (15-Apr-2021): This follow-up is being submitted to notify that the batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: arm pain at the inject site; body aches; This is a spontaneous report from a contactable consumer.   The 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration, on 27Jan2021 as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced arm pain at the inject site and body aches. The clinical outcome of events was unknown.   Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pyrexia
Clinical narrative: Headache; Fever 100; Nausea; Vomiting; Chills; This is a spontaneous report from a contactable other healthcare professional (patient). A non-pregnant 41-year-old female adult patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL3248), via an unspecified route of administration on left arm on 25Jan2021 at 11:00 AM as a single dose for COVID-19 immunization. Patient had allergies to Celexa, Mango, Mold, Penicillin, Amoxicillin, Cocoa, Dairy. Patient received Allergy Shots, Cetirizine Hydrochloride (Zyrtec), Lisinopril, Verapamil, and Amitriptyline Hydrochloride (Amit) within 2 weeks of vaccination on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID. On 01Feb2021 patient experienced Headache, Fever 100, nausea, vomiting and chills. No treatment received for the adverse events . since the vaccination, patient has not been tested for COVID-19. case has been assessed as non-serious. Outcome of all the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache; Fever 100; Nausea; Vomiting; Chills; This is a spontaneous report from a contactable other healthcare professional (patient). A non-pregnant 41-year-old female adult patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL3248), via an unspecified route of administration on left arm on 25Jan2021 at 11:00 AM as a single dose for COVID-19 immunization. Patient had allergies to Celexa, Mango, Mold, Penicillin, Amoxicillin, Cocoa, Dairy. Patient received Allergy Shots, Cetirizine Hydrochloride (Zyrtec), Lisinopril, Verapamil, and Amitriptyline Hydrochloride (Amit) within 2 weeks of vaccination on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID. On 01Feb2021 patient experienced Headache, Fever 100, nausea, vomiting and chills. No treatment received for the adverse events . since the vaccination, patient has not been tested for COVID-19. case has been assessed as non-serious. Outcome of all the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report from a contactable (Patient). A 69-year-old non-pregnant female patient received BNT162B2 (Pfizer COVID-19 Vaccine, solution for injection, Lot number: unknown), via unspecified route of administration, administered in left arm on 03Feb2021 at 15:43 (at the age of 69-years) as unknown, single dose for COVID-19 immunisation. The patient medical history included breast cancer survivor for 11 years. The patient was allergic to Viox & Celebrex. Concomitant medications were not reported. The patient did not receive any other vaccine four weeks prior vaccination and did not take any other medications prior two weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. On 03Feb2021, patient experienced diarrhea. No treatment was received for the event diarrhea. The outcome of the event was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness around injection site; This is a spontaneous report from a contactable Other Health Professional reporting for herself. This is one of two report from same reporter. A 26-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL8982; Expiry date: unknown) as a single dose for COVID-19 immunization on 13Jan2021 at 09:45 in the left arm. The patient past medical history and concomitant medications was not reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Approximately in 2021, after first dose the patient developed soreness around injection site. The patient reported that the clinical outcome for soreness around injection site was recovering. The patient did not receive any treatment for adverse event.  Follow-up attempts are completed. No further information is expected.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: This is a spontaneous report from a contactable consumer reported for herself that. A 93-years-old non-pregnant female elderly patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL3247), via an intramuscular route of administration at Right arm on 27Jan2021 12:00 PM at a single dose for COVID-19 immunization. The patient's medical history included high blood pressure, hiatal hernia, inguinal hernia and Allergies: shellfish. Concomitant medications reported as losartan potassium (LOSARTIN), levothyroxine sodium (SYNTHROID), omeprazole (PRILOSEC). On 03Feb2021 07:00 PM, Patient experienced Mild nausea. '3" on a scale of 1-10. No treatment received for the event. Patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Patient has not been tested COVID-19 before the vaccination. Seriousness of the case reported as non-serious. Patient has not been diagnosed before vaccination. Outcome of the event was unknown. No follow-up attempts are possible. No further information is expected
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: tinnitus Left ear
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Death, General physical health deterioration, Influenza like illness
Clinical narrative: My mother was in generally good health for her age, known as the strongest woman to many.  She defied covid for over a year, despite living in an assisted living facility in one of 2020's "hot zones".  After taking the vaccine, she died within 2 months.  I definitely believe 100% the vaccine in the very least hastened her health as she began declining immediately after the first dose, with on/off flu like symptoms until her death.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Nasopharyngitis, Pyrexia
Clinical narrative: fever; lingering cold symptoms; cold/flu like symptoms; This is a spontaneous report from a non-contactable consumer (patient) reported for herself.  A 39-year-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EK9231, Expiration Date: unknown), via an unspecified route of administration, administered in left arm on 07Jan2021 at 10:45 am (age at vaccination was 39 years) as 1ST DOSE, SINGLE for COVID-19 immunization. The patient's medical history included high cholesterol and pre-diabetic. The patient had known allergies to pcn and sulfa drugs. Concomitant medication patient received within 2 weeks of vaccination included ibuprofen, atorvastatin and vitamins nos (DAILY MULTIVITAMIN). On an unknown date, the patient experienced fever, cold/flu like symptoms for 4 days, lingering cold symptoms for over a week. The facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Fatigue, Lethargy, Lymphadenopathy, Migraine
Clinical narrative: This is a spontaneous report from a contactable Nurse.  A 27-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EJ1686), via intramuscular route administered on Arm Left on 25Jan2021 10:00 AM (27 year-old at the time of vaccination) as single dose for COVID-19 immunization. Patient relevant medical history included anxiety, depression, obsessive-compulsive disorder, post-traumatic stress disorder, bipolar disorder and allergies to PCN, Bactrim, Biaxin, Ceftin, Ceftezole. No other vaccine in four weeks, None other medications in two weeks. No covid prior vaccination, Yes covid tested post vaccination. There were no The patient concomitant medications were not reported. On 26Jan2021 at 08:00, the patient experienced lymph node swelling on affected side, fever, lethargy/fatigue, body aches, bruising and rash to bilateral lower extremities, migraine, nausea/vomiting. The patient underwent lab tests and procedures which included sars-cov-2 test(Nasal Swab) was negative on 28Jan2021. The patient did not receive any treatment for the events. The outcome of event was recovered. Follow-up attempts are completed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Rash, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable Nurse.  A 27-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EJ1686), via intramuscular route administered on Arm Left on 25Jan2021 10:00 AM (27 year-old at the time of vaccination) as single dose for COVID-19 immunization. Patient relevant medical history included anxiety, depression, obsessive-compulsive disorder, post-traumatic stress disorder, bipolar disorder and allergies to PCN, Bactrim, Biaxin, Ceftin, Ceftezole. No other vaccine in four weeks, None other medications in two weeks. No covid prior vaccination, Yes covid tested post vaccination. There were no The patient concomitant medications were not reported. On 26Jan2021 at 08:00, the patient experienced lymph node swelling on affected side, fever, lethargy/fatigue, body aches, bruising and rash to bilateral lower extremities, migraine, nausea/vomiting. The patient underwent lab tests and procedures which included sars-cov-2 test(Nasal Swab) was negative on 28Jan2021. The patient did not receive any treatment for the events. The outcome of event was recovered. Follow-up attempts are completed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: This is a spontaneous report from a contactable Nurse.  A 27-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EJ1686), via intramuscular route administered on Arm Left on 25Jan2021 10:00 AM (27 year-old at the time of vaccination) as single dose for COVID-19 immunization. Patient relevant medical history included anxiety, depression, obsessive-compulsive disorder, post-traumatic stress disorder, bipolar disorder and allergies to PCN, Bactrim, Biaxin, Ceftin, Ceftezole. No other vaccine in four weeks, None other medications in two weeks. No covid prior vaccination, Yes covid tested post vaccination. There were no The patient concomitant medications were not reported. On 26Jan2021 at 08:00, the patient experienced lymph node swelling on affected side, fever, lethargy/fatigue, body aches, bruising and rash to bilateral lower extremities, migraine, nausea/vomiting. The patient underwent lab tests and procedures which included sars-cov-2 test(Nasal Swab) was negative on 28Jan2021. The patient did not receive any treatment for the events. The outcome of event was recovered. Follow-up attempts are completed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection, Weight
Clinical narrative: UTI; This is a spontaneous report from a Contactable Consumer (patient, self-reported). A 64-year-old female patient (age at the time of vaccination 63 year) received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9262 and expiry date: 31May2021), via an unspecified route of administration, in Arm Left, on 25Jan2021, as a single dose for COVID-19 immunization. The patient's medical history included urinary tract infection (UTI) and it was not unusual for her to get UTI, she got them frequently. Concomitant medications were not reported. The patient reported that on 28Jan2021, she woke up with the UTI today. The patient stated that she knew they were not related because she got them periodically and asked what she could do about taking antibiotics, did that effect the efficacy of the product. The patient stated that she was scheduled to have a call with the doctor today, but he was not called yet. Usually, the doctor tells her to go on Macrobid. The patient clarified that she currently did not have an answer from the doctor yet, she was not prescribed anything yet and her UTI felt about the same. The patient's weight was 114 lbs or 115 lbs. The patient declined to provide an address; she did not want anything sent to her in the mail and they could email her. Outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Injection site cellulitis, Injection site erythema, Nausea
Clinical narrative: Redness at injection site; Cellulitis at injection site requiring antibiotics; Fatigue; Fever; Nausea; Flu like symptoms; This is a spontaneous report from a contactable Nurse (patient). A 25-year-old female non pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EJ1686, Expiration Date: not reported), via intramuscular in left arm on 25Jan2021 10:00 as 2nd dose, single for COVID-19 immunization. The patient historic vaccine included first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number and Expiration Date not reported) on 04Jan2021 09:00 AM for COVID-19 immunization. Facility type vaccine was Nursing Home/Senior Living Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was diagnosed with COVID-19 post vaccination. Medical history was not reported. Patient did not had known allergies and other medical history was reported as none. Concomitant medication included multivitamin in two weeks taken for an unspecified indication. The patient experienced redness at injection site, cellulitis at injection site requiring antibiotics, fatigue, fever, nausea and flu like symptoms on 26Jan2021 06:00. AE resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures included COVID test post vaccination: Nasal Swab on 28Jan2021, Negative. AE treatment was received antibiotics r/t cellulitis. The outcome of the events was reported as recovering.  Follow-up attempts are completed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Viral test
Clinical narrative: Redness at injection site; Cellulitis at injection site requiring antibiotics; Fatigue; Fever; Nausea; Flu like symptoms; This is a spontaneous report from a contactable Nurse (patient). A 25-year-old female non pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EJ1686, Expiration Date: not reported), via intramuscular in left arm on 25Jan2021 10:00 as 2nd dose, single for COVID-19 immunization. The patient historic vaccine included first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number and Expiration Date not reported) on 04Jan2021 09:00 AM for COVID-19 immunization. Facility type vaccine was Nursing Home/Senior Living Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was diagnosed with COVID-19 post vaccination. Medical history was not reported. Patient did not had known allergies and other medical history was reported as none. Concomitant medication included multivitamin in two weeks taken for an unspecified indication. The patient experienced redness at injection site, cellulitis at injection site requiring antibiotics, fatigue, fever, nausea and flu like symptoms on 26Jan2021 06:00. AE resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures included COVID test post vaccination: Nasal Swab on 28Jan2021, Negative. AE treatment was received antibiotics r/t cellulitis. The outcome of the events was reported as recovering.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site infection, Injection site pain, Lymphadenopathy, Migraine
Clinical narrative: Tenderness at injection site; swollen lymph nodes on affected injection site; swollen lymph nodes on affected injection site; fever; joint pain; migraine; This is a spontaneous report from a contactable nurse. A 40-year-old female non-pregnant patient received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EJ1686) intramuscularly in left arm on an unspecified date as a single dose for covid-19 immunization. The patient did not receive vaccine in four weeks. The patient's medical history included migraines, constipation, celiac disease, chronic pain r/t injury. The patient's concomitant medication included topamax, adderall, tramadol, maxalt, carprofen, oral birth control, linzess. The patient was not diagnosed with COVID prior vaccination. The patient was not diagnosed with COVID prior vaccination. Previously, the patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection), via unknown route of administration on an unknown date as a single dose for covid-19 immunization. On 25Jan2021 at 20:00, the patient experienced tenderness at injection site, swollen lymph nodes on affected injection site, fever, joint pain, migraine. The patient did not receive any treatment for the events. The patient tested to COVID-19 swab test on 28Jan2021 and showed negative. The outcome of the events was recovering.  Follow-up attempts are completed. No further information was expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Tenderness at injection site; swollen lymph nodes on affected injection site; swollen lymph nodes on affected injection site; fever; joint pain; migraine; This is a spontaneous report from a contactable nurse. A 40-year-old female non-pregnant patient received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EJ1686) intramuscularly in left arm on an unspecified date as a single dose for covid-19 immunization. The patient did not receive vaccine in four weeks. The patient's medical history included migraines, constipation, celiac disease, chronic pain r/t injury. The patient's concomitant medication included topamax, adderall, tramadol, maxalt, carprofen, oral birth control, linzess. The patient was not diagnosed with COVID prior vaccination. The patient was not diagnosed with COVID prior vaccination. Previously, the patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection), via unknown route of administration on an unknown date as a single dose for covid-19 immunization. On 25Jan2021 at 20:00, the patient experienced tenderness at injection site, swollen lymph nodes on affected injection site, fever, joint pain, migraine. The patient did not receive any treatment for the events. The patient tested to COVID-19 swab test on 28Jan2021 and showed negative. The outcome of the events was recovering.  Follow-up attempts are completed. No further information was expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm when lifted at a right angle and above her head; This is a spontaneous report from a non-contactable consumer (patient). A 44-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiry date: Unknown), via an unspecified route of administration on an unknown date in Jan2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine included Tetanus shot hurt more and had pain. On 27Jan2021, the patient experienced pain in arm and described it as there was no pain when arm was down, but she did experience pain when she lifted her arm at a right angle and above her head. The patient stated that Tetanus shot hurted more compared to this pain. She stated that the pain reached its peak about 12 hours ago and subsided at the time of report. At the time of report, the patient did not receive second dose of COVID-19 Vaccine. The outcome of the event was reported as recovering.  No follow up attempts are possible. Information about lot/batch number cannot not be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Headache, Pain in extremity, Sluggishness
Clinical narrative: This is a spontaneous report from a non-contactable 43-year-old female Nurse (patient, self-reported). A 43-year-old non-pregnant female received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: unknown; reason was misplaced/discarded and Expiration Date: unknown), unspecified dose via an unspecified route of administration in left arm, on 03Feb2021 13:30 (age at the time of vaccination was 43 years) as single for COVID-19 immunization in the hospital. The patient's medical history and concomitant medications were not reported. The patient did not receive other medications within 2 weeks of vaccination. No allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 03Feb2021 at 19:00, the patient experienced fatigue, sense of heaviness and sluggishness, headache, and dull throbbing pain in right lower anterior leg unrelieved by massage or rest. No treatment medications were reported. The reported assessed events as non-serious. The outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness, Tachycardia, Throat irritation
Clinical narrative: This is a spontaneous report was received from a contactable physician (Patient). A 38-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 07Jan2021 as single dose for COVID-19 immunization. The patient had no other medical history, and the patient was not taking concomitant medications. There were no known allergies reported. The patient was not pregnant at the time of vaccination. On 07Jan2021, the patient experienced Immediate dizziness and tachycardia after the shot. 30 minutes after receiving the vaccine, throat itching, dizziness, abdominal cramps. As result of event patient was in Emergency room/department or urgent care. Patient did not receive any treatment for event. Patient did not receive any other vaccine in four weeks. It was not available whether the patient was taking other medications in two weeks. Patient did not have Covid prior vaccination. Patient did not test Covid post vaccination. The outcome of event was recovered on an unspecified date in 2021. Information on the lot/batch number has been requested. Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: My arm, I can hardly lift it all the way up; Arm hurts; Nauseous; This is a spontaneous report received from a contactable consumer (reporting on herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL3249and Expiration Date was not reported) via an unspecified route of administration on 27Jan2021, as unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  It was reported that patient had the (incomplete sentence) she went on this morning and took snap shot. she put everything on but it says she got the vaccine today but she didn't get it today, she got it yesterday. So, patient wanted to tell them about what she feeling because her arm, she can hardly lift it all the way up and she was nauseous.  Patient stated but she can't on the site. It says she was all set, it has a wrong date, and you are not assisting me. It says she got the injection today but she got it yesterday and she can't change that from her profile. She want to know how she registered that she having side effects. Patient took two Ibuprofen last night. Patient have an issue, her arm hurts. She would like to speak to somebody about that.  The outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dyspnoea, Nausea, Palpitations
Clinical narrative: Fast heart beat with palpitations; Tightness in chest felt like burning; Tightness in chest felt like burning; Shortness of breath; Extreme nausea; This is a spontaneous report from a contactable other HCP (patient). A 61-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN5318), via an unspecified route of administration on 31Jan2021 at 10:45 in right arm as 2ND DOSE SINGLE for covid-19 immunization. Medical history included asthma, coronary artery vasospasm. The patient took lidocaine and experienced allergies. The patient had received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient's concomitant medications were not reported. The patient previous vaccine included first dose of BNT162B2 (COVID Pfizer vaccine, solution for injection; Batch/Lot Number: EN1204) on 10Jan2021 at 10:45 in right arm for COVID-19 immunization. The patient experienced fast heartbeat with palpitations, tightness in chest felt like burning (coded to chest discomfort and chest pain), shortness of breath and extreme nausea on 31Jan2021. Five days later also she had shortness of breath felt like asthma. She also experienced fast heartbeat with palpitations. The events were reported as non-serious. The patient did not receive any treatment for the adverse event. The outcome of all events was not recovered/not resolved.  Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Hypoaesthesia, Paraesthesia, Pruritus
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot Number: EL9262, expiration date unknown), via an unspecified route of administration on 27Jan2021 at 08:30, as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  It was reported that, the patient stated that after taking first dose of vaccine on 27Jan2021, he/she sat there 15 minutes and felt fine but then got on the road to go to job like 10 minutes after or so and the right side of his/her face started burning and tingling, almost like if you get a novocaine shot if you have your tooth pulled, it was sort of like that numbing, numb, tingling feeling it was still there this morning and asked if it will that subside and also stated that there was burning and itching. The patient was just wondering what to do about the burning and itching and mentioned that it was not bad but knew that it was there. The outcome was unknown for the event itching (pruritus) and was not recovered from other events. Follow-up attempts are completed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Back pain, Decreased appetite, Fatigue
Clinical narrative: I am still very fatigued, no appetite, weakness, and stomach ache; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; This is a spontaneous report from a non-contactable health professional. A 43-year-old non pregnant female patient received second dose of BNT162B2 (BNT162B2, solution for injection), via an unspecified route of administration in Arm Left on 21Jan2021 as single dose for covid-19 immunisation. Facility where COVID-19 vaccine was administered was hospital. The patient medical history was not reported. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included clonazepam. Known allergies is none. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (BNT162B2, solution for injection), on 21Jan2021 in the left arm at single dose for COVID-19 immunisation. On 22Jan2021 the patient experienced Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving. The patient stated that I am still very fatigued, no appetite, weakness, and stomach ache. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 14Dec2020. Outcome of the events were not recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: I am still very fatigued, no appetite, weakness, and stomach ache; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving.; This is a spontaneous report from a non-contactable health professional. A 43-year-old non pregnant female patient received second dose of BNT162B2 (BNT162B2, solution for injection), via an unspecified route of administration in Arm Left on 21Jan2021 as single dose for covid-19 immunisation. Facility where COVID-19 vaccine was administered was hospital. The patient medical history was not reported. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included clonazepam. Known allergies is none. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (BNT162B2, solution for injection), on 21Jan2021 in the left arm at single dose for COVID-19 immunisation. On 22Jan2021 the patient experienced Very fatigued, muscles in legs ache, nausea, no appetite, headache, weakness, soreness where the injection was, lower back pain to the point of being in tears with any moving. The patient stated that I am still very fatigued, no appetite, weakness, and stomach ache. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 14Dec2020. Outcome of the events were not recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection site; This is a spontaneous report received from a contactable consumer or other non hcp.   A 57-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported, Pfizer NTEC), via an unspecified route of administration in Arm Right on 04Feb2021 09:15 AM as single dose for covid-19 immunisation. Medical history included prehypertension, blood cholesterol increased and G6PD allergy. Concomitant medications included amlodipine Besylate (strength 2.5 mg) and rosuvastatin (strength 5mg) (list of medications the patient received within 2 weeks of vaccination). In Hospital the most recent COVID-19 vaccine was administered. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. The patient experienced soreness at injection site on 05Feb2021 04:00 AM. The events assessed as non-serious. No treatment was received for the events. Since the vaccination, did not patient been tested for COVID-19. The outcome of the events was reported as recovering.   Follow-up attempts completed. No further information expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site sore; This is a spontaneous report from a non-contactable consumer (patient herself). A 45-year-old female received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number-UNKNOWN) via an unspecified route of administration in left arm on 14Jan2021 as 1st single dose and received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EL3248) via an unspecified route of administration in right arm on 04Feb2021 09:15 as 2nd dose single for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was reported as Workplace clinic. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any prior COVID-19 vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. The patient has not been tested for COVID-19, since the vaccination. Patient was 45-years-old and was not pregnant at the time of vaccination. Patient medical history was not reported. The concomitant medications levocabastine hydrochloride (ZYRTEC) at a dose of 10 mg. On 14Jan2021, patient experienced injection site pain in left arm and on 04Feb2021, patient experienced injection site pain in right arm. The patient did not receive any treatment for the adverse events. The outcome of the event was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: I can't taste anything; This is a spontaneous report from a contactable consumer. A patient of an unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration date was not reported), via an unspecified route of administration on 26Jan2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 28Jan2021, the patient ate breakfast, felt everything was fine and then had another small breakfast and suddenly was not able to taste anything. The outcome of the event was unknown.    Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: sore shoulder; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration on 25Jan2021 at 10:00 as unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On 26Jan2021, patient had a sore shoulder the next morning and then it was gone. Stated it was the normal thing that would happen. The outcome of the event was recovered.  Information about Lot/ Batch number requested  Follow-up (19Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made.   Follow-up attempts have been completed and no further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Fatigue, Feeling abnormal, Feeling cold, Headache
Clinical narrative: Slight Injection site pain; Brain fog; Immediate HA; Feeling cold; Dry/cold mouth; Fatigue; This is a spontaneous report from a contactable Nurse. A 64-year-old (non pregnant) female patient received bnt162b2 (Pfizer-BioNTech covid-19 vaccine, Solution for injection Batch/Lot Number: EN5318) dose 1 via an unspecified route of administration in arm right on 26Jan2021 15:45 PM (at the age of 64-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included high blood pressure, meniere's disease, infrequent cluster migraines, arthritis, tendonitis from an unknown date and unknown if ongoing. The patient previously took emetrex and experienced drug hypersensitivity. Concomitant medications (other medications in two weeks) included armour thyroid, pantoprazole, biotin, B160/40/Pro/E taken for an unspecified indication, start and stop date were not reported. The patient did not have any other vaccine in four weeks. The patient did not receive any treatment for adverse events. The patient did not have COVID prior vaccination. And post vaccination patient had not tested for COVID. On 26Jan2021 at 04:00 PM, she had slight injection site pain, brain fog, immediate HA, feeling cold, dry/cold mouth and fatigue. The outcome of the events was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Slight Injection site pain; Brain fog; Immediate HA; Feeling cold; Dry/cold mouth; Fatigue; This is a spontaneous report from a contactable Nurse. A 64-year-old (non pregnant) female patient received bnt162b2 (Pfizer-BioNTech covid-19 vaccine, Solution for injection Batch/Lot Number: EN5318) dose 1 via an unspecified route of administration in arm right on 26Jan2021 15:45 PM (at the age of 64-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included high blood pressure, meniere's disease, infrequent cluster migraines, arthritis, tendonitis from an unknown date and unknown if ongoing. The patient previously took emetrex and experienced drug hypersensitivity. Concomitant medications (other medications in two weeks) included armour thyroid, pantoprazole, biotin, B160/40/Pro/E taken for an unspecified indication, start and stop date were not reported. The patient did not have any other vaccine in four weeks. The patient did not receive any treatment for adverse events. The patient did not have COVID prior vaccination. And post vaccination patient had not tested for COVID. On 26Jan2021 at 04:00 PM, she had slight injection site pain, brain fog, immediate HA, feeling cold, dry/cold mouth and fatigue. The outcome of the events was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.